Brief: Novan Inc Reported Qtrly Loss Per Share $0.34

NVN Liquidation

10/11/2021 12:12

Nov 10 (Reuters) - Novan Inc  NOVN.O :
    * NOVAN INC - SEES SB019 IND SUBMISSION TO INITIATE PHASE 1
STUDY
IN HEALTHY VOLUNTEERS TARGETED FOR NO LATER THAN Q2 2022
    * NOVAN INC - QTRLY LOSS PER SHARE $0.34
    * NOVAN PROVIDES CORPORATE UPDATE AND REPORTS THIRD QUARTER
2021
FINANCIAL RESULTS
    * NOVAN INC - BELIEVES EXISTING CASH AND CASH EQUIVALENTS
BALANCE
AS OF SEPT 30, WILL PROVIDE ADEQUATE LIQUIDITY TO FUND OPERATING
NEEDS INTO Q4 OF 2022
    * NOVAN INC - SEES SB019 PHASE 2/3 STUDY(IES) TARGETED FOR
2023,
SUBJECT TO OBTAINING ADDITIONAL FINANCING OR STRATEGIC
PARTNERING
    * NOVAN INC - SEES POTENTIAL SUBMISSION OF AN SB019 NDA IN
2024
    * NOVAN - EXECUTING ON PLANS FOR 3 POTENTIAL NDA FILINGS IN
3
YEARS WITH FIRST SUBMISSION IN Q3 2022 FOR LEAD PROGRAM SB206 IN
MOLLUSCUM CONTAGIOSUM

Further company coverage:  NOVN.O 

 (Reporting by Nandhini Srinivasan)
 ((Nandhini.Srinivasan@thomsonreuters.com;))